Repare Therapeutics Inc. - Common shares, no par value (RPTX)

CUSIP: 760273102

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common shares, no par value
Shares outstanding
42,837,925
Total 13F shares
35,509,240
Share change
-1,005,744
Total reported value
$167,234,827
Put/Call ratio
16%
Price per share
$4.71
Number of holders
70
Value change
-$6,368,867
Number of buys
22
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 760273102?
CUSIP 760273102 identifies RPTX - Repare Therapeutics Inc. - Common shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q1 2024

As of 31 Mar 2024, Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,509,240 shares. The largest 10 holders included BVF INC/IL, ORBIMED ADVISORS LLC, Blue Owl Capital Holdings LP, ARK Investment Management LLC, Deep Track Capital, LP, Versant Venture Management, LLC, MPM ASSET MANAGEMENT LLC, Redmile Group, LLC, MPM BIOIMPACT LLC, and Artal Group S.A.. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.